Published

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Clinical pharmacokinetics
Date: 2017-12-01
Source: PubMed
DOI: 10.1007/s40262-017-0540-6
PubMed: 28353056

Authors

Brown RT Nicholas CR Cozzi NV Gassman MC Cooper KM Muller D Thomas CD Hetzel SJ Henriquez KM Ribaudo AS Hutson PR

Watch author

Derived topics and classifications

psilocybin psilocin Depression Addiction Pharmacology Clinical Trial Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 18 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety2026-08-12 Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 Explainable AI framework for psilocybin depression treatment optimization2026-03-16 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure2026-02-12 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress2026-01-02 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method2024-08-01 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01 Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans2021-03-15 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01 Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin2021-01-01 Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin2020-07-14 Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels2019-06-01 Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.2017-12-01